Oncology Institute (DFPH) EBITDA Margin Growth (1y) (2022 - 2026)
Oncology Institute (DFPH) EBITDA Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 87.94 Bn | 90.32 Bn | 16.26 Bn | 532.00 |
| 2 | Chemed | 18.08 Bn | 18.07 Bn | 215.76 Mn | -169.00 |
| 3 | Tenet Healthcare | 16.59 Bn | 15.76 Bn | 4.41 Bn | 609.00 |
| 4 | Davita | 15.37 Bn | 16.23 Bn | 1.07 Bn | 49.00 |
| 5 | Encompass Health | 10.07 Bn | 10.70 Bn | 1.34 Bn | -974.00 |
| 6 | Ensign | 9.52 Bn | 8.93 Bn | 293.37 Mn | 35.00 |
| 7 | Universal Health Services | 9.19 Bn | 9.15 Bn | 3.21 Bn | 9.00 |
| 8 | Pacs | 6.96 Bn | 6.72 Bn | 345.96 Mn | 622.00 |
| 9 | Ww International | 6.14 Bn | 5.98 Bn | -149.29 Mn | -264.00 |
| 10 | Oncology Institute | - | - | 139.16 Mn | 472.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 472.00 |
| Dec 31, 2025 | 675.00 |
| Sep 30, 2025 | 790.00 |
| Jun 30, 2025 | 735.00 |
| Mar 31, 2025 | 970.00 |
| Dec 31, 2024 | 591.00 |
| Sep 30, 2024 | 279.00 |
| Jun 30, 2024 | 203.00 |
| Mar 31, 2024 | 2,420.00 |
| Dec 31, 2023 | 1,759.00 |
| Sep 30, 2023 | 1,446.00 |
| Jun 30, 2023 | 1,158.00 |
| Mar 31, 2023 | -951.00 |
| Dec 31, 2022 | 4,310.00 |
| Sep 30, 2022 | -2,663.00 |
| Jun 30, 2022 | -2,756.00 |
| Mar 31, 2022 | -2,965.00 |